Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL H SHANIK

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1386775740
CMS profile
153116
Location
SMITHTOWN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$82,804.54

266 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 6; records 51–100 of 266 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL H SHANIK

NPI 1386775740 · CMS profile ID 153116

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

SMITHTOWN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 6; records 51–100 of 266 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1386775740?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL H SHANIK, NPI 1386775740, CMS profile ID 153116. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 266 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1386775740?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MICHAEL H SHANIK, NPI 1386775740, CMS profile ID 153116. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 266 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1386775740?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MICHAEL H SHANIK, NPI 1386775740, CMS profile ID 153116, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 6; records 51–100 of 266 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1386775740?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

266 matching records · $82,804.54 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 266 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 266.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $11.8210/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810858967 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.9010/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763770958 CMS
AbbVie Inc. $22.0510/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796016903 CMS
Antares Pharma, Inc. $22.4610/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827476337 CMS
Novo Nordisk Inc $5.0010/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811240563 CMS
Novo Nordisk Inc $34.7210/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811658209 CMS
Novo Nordisk Inc $120.3010/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811658213 CMS
Novo Nordisk Inc $2,210.0010/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811658215 CMS
Corcept Therapeutics $13.8410/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837535615 CMS
Amgen Inc. $19.0010/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825616677 CMS
Novo Nordisk Inc $2,210.0010/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811746073 CMS
Bayer HealthCare Pharmaceuticals Inc. $15.5710/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789095779 CMS
Novo Nordisk Inc $5.0010/14/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810858943 CMS
Novo Nordisk Inc $22.4010/14/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810858955 CMS
Novo Nordisk Inc $119.2910/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811240559 CMS
Novo Nordisk Inc $2,210.0010/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811746071 CMS
Lilly USA, LLC $19.3810/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818670585 CMS
Althera Pharmaceuticals LLC $16.5210/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800372431 CMS
MannKind Corporation $15.1610/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821079615 CMS
MannKind Corporation $15.1610/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821079619 CMS
Amneal Pharmaceuticals LLC $14.2709/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829678779 CMS
Novo Nordisk Inc $867.0009/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811746067 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.8509/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763770960 CMS
Novo Nordisk Inc $24.8909/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811532317 CMS
Novo Nordisk Inc $12.5109/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811386215 CMS
Novo Nordisk Inc $33.6009/24/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810858935 CMS
Novo Nordisk Inc $125.0109/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811064433 CMS
Novo Nordisk Inc $2,210.0009/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811658207 CMS
Novo Nordisk Inc $121.7109/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810858927 CMS
Novo Nordisk Inc $34.7209/23/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811064419 CMS
Novo Nordisk Inc $2,635.0009/23/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811064425 CMS
SANOFI-AVENTIS U.S. LLC $17.8909/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843613693 CMS
Lilly USA, LLC $23.4609/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860804777 CMS
Amarin Pharma Inc. $18.0509/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815339753 CMS
Lilly USA, LLC $1,575.0009/16/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818663075 CMS
Corcept Therapeutics $15.2109/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837535619 CMS
Bayer HealthCare Pharmaceuticals Inc. $16.1409/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789103525 CMS
Janssen Pharmaceuticals, Inc $16.6709/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788183985 CMS
Kowa Pharmaceuticals America, Inc. $11.3309/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 805576457 CMS
IBSA Pharma Inc. $21.0608/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792516869 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.6708/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763770962 CMS
Amgen Inc. $14.0308/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825616673 CMS
Alfasigma USA, Inc. $14.3708/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853046583 CMS
Novo Nordisk Inc $124.9908/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810714899 CMS
Novo Nordisk Inc $5.0008/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811240553 CMS
Novo Nordisk Inc $2,210.0008/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811532313 CMS
Novo Nordisk Inc $34.7208/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811658203 CMS
AbbVie Inc. $17.8308/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796016901 CMS
Regeneron Healthcare Solutions, Inc. $24.3508/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809623929 CMS
Xeris Pharmaceuticals, Inc. $21.6608/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837444777 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $184,107.88 441
PY2020 $116,150.33 269
PY2021 $82,804.54 266
PY2022 $175,736.80 352
PY2023 $130,539.98 350
PY2024 $179,948.24 406
PY2025 $321,017.22 517

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $136,686.79 36
PY2024 Principal investigator $72,323.00 19
PY2023 Principal investigator $31,534.77 27
PY2022 Principal investigator $49,374.39 225
PY2021 Principal investigator $58,482.27 456
PY2020 Principal investigator $54,153.94 20
PY2019 Principal investigator $64,830.84 22

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

36 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,520.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202533851
Principal investigator 1 ABBVIE INC. $556.47 12/11/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202530264
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,935.00 12/04/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223289228
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $587.00 11/14/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223288301
Principal investigator 1 ABBVIE INC. $6,347.70 11/05/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202521505
Principal investigator 1 ABBVIE INC. $3,505.95 10/09/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202513781
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,174.00 10/09/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223286619
Principal investigator 1 ABBVIE INC. $375.68 10/02/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202513039
Principal investigator 1 ABBVIE INC. $3,001.62 09/18/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202511404
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $12,650.00 09/10/2025 Non-covered Recipient Entity
Endocrine Associates Of Long Island
A simultaneous vs. staggered initiation study of BI 690517 and empagliflozin for SGLT2i treatment-naive participants with CKD No dispute reported 06/30/2026 1220817676
Principal investigator 1 ABBVIE INC. $10,573.20 09/04/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202509166
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $587.00 09/04/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223285101
Principal investigator 1 Boehringer Ingelheim International GmbH $46.88 09/01/2025 Non-covered Recipient Entity
Endocrine Associates Of Long Island
A simultaneous vs. staggered initiation study of BI 690517 and empagliflozin for SGLT2i treatment-naive participants with CKD No dispute reported 06/30/2026 1220784409
Principal investigator 1 Boehringer Ingelheim International GmbH $58.30 08/26/2025 Non-covered Recipient Entity
Endocrine Associates Of Long Island
A simultaneous vs. staggered initiation study of BI 690517 and empagliflozin for SGLT2i treatment-naive participants with CKD No dispute reported 06/30/2026 1220784411
Principal investigator 1 Boehringer Ingelheim International GmbH $159.84 08/26/2025 Non-covered Recipient Entity
Endocrine Associates Of Long Island
A simultaneous vs. staggered initiation study of BI 690517 and empagliflozin for SGLT2i treatment-naive participants with CKD No dispute reported 06/30/2026 1220784413
Principal investigator 1 Boehringer Ingelheim International GmbH $36.50 08/26/2025 Non-covered Recipient Entity
Endocrine Associates Of Long Island
A simultaneous vs. staggered initiation study of BI 690517 and empagliflozin for SGLT2i treatment-naive participants with CKD No dispute reported 06/30/2026 1220784415
Principal investigator 1 ABBVIE INC. $2,802.60 08/06/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202503307
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,174.00 07/31/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223283286
Principal investigator 1 ABBVIE INC. $3,171.15 07/02/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202494351
Principal investigator 1 AstraZeneca Pharmaceuticals LP $13,550.00 06/23/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND, PC
A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of Zibotentan/Dapagliflozin FDC Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease and High Proteinuria No dispute reported 06/30/2026 1185549723
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $587.00 06/12/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223281156
Principal investigator 1 ABBVIE INC. $13,649.85 06/03/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202487985
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $587.00 05/15/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223279810
Principal investigator 1 ABBVIE INC. $5,593.05 05/07/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202484013
Principal investigator 1 AstraZeneca Pharmaceuticals LP $9,000.00 04/30/2025 Non-covered Recipient Entity
HIGHLAND MEDICAL HEMATOLOGY AND ONCOLOGY
A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of Zibotentan/Dapagliflozin FDC Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease and High Proteinuria No dispute reported 06/30/2026 1185549721
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,174.00 04/22/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223278536
Principal investigator 1 ABBVIE INC. $5,686.20 04/03/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202473343
Principal investigator 1 ABBVIE INC. $9,868.50 03/07/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202459720
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $587.00 03/06/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223276073
Principal investigator 1 Ascendis Pharma Endocrinology Inc $1,000.00 03/05/2025 Non-covered Recipient Entity
Endocrine Associates of Long Island, PC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233994993
Principal investigator 1 Ascendis Pharma Endocrinology Inc $700.00 03/05/2025 Non-covered Recipient Entity
Endocrine Associates of Long Island, PC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995021
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $587.00 02/13/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223275231
Principal investigator 1 ABBVIE INC. $8,904.60 02/06/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202448395
Principal investigator 1 Novartis Pharmaceuticals Corporation $4,500.00 02/05/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND, PC
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1190305329
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $587.00 01/09/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES OF LONG ISLAND PC
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223273839
Principal investigator 1 ABBVIE INC. $4,862.70 01/02/2025 Non-covered Recipient Entity
ENDOCRINE ASSOCIATES
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202434883